MedPage Today Cardiovascular

  • Updated:Feb 24,2014
  • Low Carb Beats Low Fat for Weight Loss, CV Risk (CME/CE)

    Sep 1, 2014 4:00 PM | (MedPage Today) -- For weight loss and for reducing cardiovascular risk, cutting down on carbs was a more effective strategy than limiting fat intake in a randomized trial, researchers found.
  • ESC: Left or Right Nerve Stimulation Feasible in HF

    Sep 1, 2014 1:38 PM | BARCELONA (MedPage Today) -- Stimulation of either the right or left vagus nerve appeared to improve cardiac function in patients with heart failure, researchers said here.
  • ESC: See It, Fix It Approach Superior in CvLPRIT

    Sep 1, 2014 11:21 AM | BARCELONA (MedPage Today) -- Moving beyond the lesion that triggers a myocardial infarction to revascularize other occluded, but nonculprit arteries reduced the risk of subsequent heart attacks and mortality, according to results from the CvLPRIT trial.
  • ESC: More Ablation Not Better for Persistent Afib

    Sep 1, 2014 11:01 AM | BARCELONA (MedPage Today) -- Doing more radiofrequency ablation for persistent atrial fibrillation beyond pulmonary vein isolation doesn't improve outcomes and takes longer, with more radiation exposure, researchers reported here.
  • ESC: Heart Energy May Be Enough to Drive Pacemaker

    Sep 1, 2014 9:49 AM | BARCELONA (MedPage Today) -- The motion of the heart may be sufficient to power a batteryless pacemaker, researchers said here.
  • ESC: Ultrathin Stent Proves Mettle in Post-PCI Patients (CME/CE)

    Sep 1, 2014 2:00 AM | BARCELONA (MedPage Today) -- An ultrathin biodegradable sirolimus-eluting stent (Orsiro) proved noninferior to a durable polymer everolimus-eluting stent (Xience) a year after percutaneous coronary intervention, researchers reported here.
  • ESC: No Pre-PCI Boost from Brilinta in Ambulance (CME/CE)

    Sep 1, 2014 2:00 AM | BARCELONA (MedPage Today) -- Giving the antiplatelet drug ticagrelor (Brilinta) in the ambulance to patients with acute ST-segment elevation myocardial infarction didn't improve coronary reperfusion before percutaneous coronary intervention, researchers reported here.
  • ESC: Evidence Mounts for Injection to Lower LDL-C (CME/CE)

    Aug 31, 2014 11:55 AM | BARCELONA (MedPage Today) -- Four studies testing the injectable novel lipid-lowering agent alirocumab found the drug dramatically reduced LDL-cholesterol (LDL-C) among high-risk patients who had not achieved LDL targets using maximum tolerated statin therapy and/or ezetimibe.
  • ESC: Nerve Stimulation No Help in Heart Failure (CME/CE)

    Aug 31, 2014 10:34 AM | BARCELONA (MedPage Today) -- Stimulating the vagus nerve didn't improve cardiac function in heart failure patients, researchers reported here.
  • ESC: Quadripolar Tops Bipolar in Cardiac Pacing (CME/CE)

    Aug 31, 2014 10:05 AM | BARCELONA (MedPage Today) -- Quadripolar left ventricle lead technology dramatically reduced perioperative complications in implanting cardiac pacemakers for cardiac resynchronization therapy, researchers reported here.
  • ESC: Ivabradine Flops in CAD Trial (CME/CE)

    Aug 31, 2014 9:30 AM | BARCELONA (MedPage Today) -- Ivabradine, a novel heart-rate reducing agent, increased the likelihood of death or heart attack when given to patients with activity-limiting angina who were already receiving standard background therapy for stable coronary artery disease.
  • ESC: Darapladib Fails in ACS Trial (CME/CE)

    Aug 31, 2014 2:00 AM | BARCELONA (MedPage Today) -- Inhibiting an enzyme involved in inflammation has once again failed to reduce cardiovascular events, this time in patients who had been hospitalized with an acute coronary syndrome event, researchers reported here.
  • ESC: Gout Drug Gets Thumbs Down in Heart Surgery

    Aug 30, 2014 2:08 PM | BARCELONA (MedPage Today) -- Findings from two trials suggested the gout drug colchicine may not be all that useful for heart surgery patients, researchers said here.
  • PodMed: A Medical News Roundup From Johns Hopkins (with audio)

    Aug 30, 2014 1:00 PM | (MedPage Today) -- This week's topics include treating adolescent depression, self management of hypertension, transmissibility of MERS, and cardiovascular events around the world.
  • ESC: Novel Heart Failure Drug a Game-Changer (CME/CE)

    Aug 30, 2014 6:00 AM | BARCELONA (MedPage Today) -- An investigational heart failure drug being developed by Novartis cut deaths from heart disease by 20% compared with standard therapy, researchers reported today at the European Society of Cardiology.